Clinical Trials Directory

Trials / Unknown

UnknownNCT02282787

Dexmedetomidine Adjuvant in Retinal Surgery

DEXMEDETOMIDINE ADJUVANT TO LOCAL ANAESTHESIA FOR PERIBULBAR BLOCKS IN RETINAL SURGERY

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
King Saud University · Academic / Other
Sex
All
Age
40 Years – 90 Years
Healthy volunteers
Not accepted

Summary

During LA in retinal surgery there is some problem as regard the lack of anaesthesia duration and unexpected globe movement .so many adjuvant was added to LA to overcome this disadvantages of LA such as clonidine and fentanyl . The investigators hypothesis is adding dexmedetomidine to pribulbal blocking LA will prolong anaesthesia duration and improve globe akinesia and decrease intraoperative supplementation of LA.There are Many studies had described the effects of dexmedetomidine on peripheral nerve blocks, spinal but up to date no knowledge is available on the impact of dexmedetomidine adjuvant to local anaesthetic in ophthalmic surgery

Conditions

Interventions

TypeNameDescription
DRUGDEXMEDETOMIDINEDoes adding 5 or 10 micron of DEXMEDETOMIDINE to peribulbar anesthesia is any different from regular peribulbar anesthesia practice?

Timeline

Start date
2014-01-01
Primary completion
2015-01-01
Completion
2015-05-01
First posted
2014-11-04
Last updated
2015-03-31

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT02282787. Inclusion in this directory is not an endorsement.

Dexmedetomidine Adjuvant in Retinal Surgery (NCT02282787) · Clinical Trials Directory